The chemical reaction method is one of the most employed and inexpensive methods to synthesize SN. It is based on the use of a reducing agent (e.g., sodium citrate) to reduce Ag + to Ag 0 and a stabilizer [e.g., ammonia (NH 3 ), polyvinylpyrrolidone (PVP)] to control particle growth and prevent aggregation (Kvítek et al. 2008; Gorup et al. 2011; Monteiro et al. 2012) . The SN action mechanism against bacterial and fungal cells is relatively well described (Monteiro et al. 2009) , and as, according to Allaker (2010) , silver may act on a broad range of microbial targets, many mutations need to occur for micro-organisms to resist its antimicrobial effect. Moreover, an inverse relationship between SN size and antimicrobial activity has been demonstrated by Baker et al. (2005) , who reported that smaller particles, with a larger surface area available for interaction with planktonic microbial cells, were more effective than larger particles.
Although the activity of SN against C. albicans and C. glabrata adhered cells and biofilms was demonstrated recently (Monteiro et al. 2011) , research regarding the susceptibility of Candida biofilms to SN of different sizes, and synthesized with different stabilizing agents, is unknown at the moment. For this reason, the current study investigated, through the quantification of total biomass and cultivable cells, the size-dependent antifungal activity against C. albicans and C. glabrata biofilms of SN synthesized with two different stabilizing agents. The null hypotheses were that: (i) there would be no difference among the different sizes of SN in decreasing total biomass and cultivable cells of Candida biofilms, and (ii) the type of stabilizing agent would not interfere with SN efficacy.
Materials and methods

Synthesis and characterization of silver colloidal nanoparticles
For the synthesis of silver colloidal nanoparticles, silver nitrate (AgNO 3 ), sodium citrate (Na 3 C 6 H 5 O 7 ) and ammonia (NH 3 ) were provided by Merck KGaA (Darmstadt; Germany) and PVP was obtained from Sigma-Aldrich, (St Louis, MO). SN of three different sizes: 5 (SN5), 10 (SN10) and 60 (SN60) nm, and stabilized with NH 3 (N) or PVP (P), were prepared according to the procedure reported by Gorup et al. (2011) . Briefly, 7AE5 ml of a solution of sodium citrate at 0AE3 mol l )1 and five drops of ammonia (1AE4 mol l )1 ) were added to a tri-neck flask containing 150 ml of an aqueous solution of AgNO 3 at 5AE0 · 10 )3 mol l )1 under the temperature of 90°C. The solution was kept stirring at 90°C until it turned yellow, indicating the formation of SN. The silver colloidal nanoparticles were stabilized by adding 7AE5 ml of a solution with 1AE4 mol l )1 of NH 3 . The new solution was kept stirring and heating for two more minutes, and the suspension was then allowed to cool at room temperature. In another flask, 1 ml of a solution of 102 g l )1 of PVP was added to the colloidal silver after lowering of the temperature. To characterize the silver colloidal nanoparticles suspensions, UV ⁄ Visible absorption spectroscopy (Spectrophotometer Shimadzu MultSpec-1501; Shimadzu Corporation, Tokyo, Japan) and Transmission Electron Microscopy (TEM, Electron Microscope FEG-VP Supra 35; Carl Zeiss, Jena, Thüringen, Germany) were performed.
Yeast strains and growth conditions
The nutrient source for biofilm formation was artificial saliva, used to mimic the in vivo oral cavity conditions. It was prepared according to Lamfon et al. (2003) and its composition per 1 l of deionized water was: 2 g of yeast extract (Liofilchem, Roseto degli Abruzzi, Italy), 5 g of peptone (Liofilchem), 2 g of glucose (AppliChem, Darmstadt, Germany), 1 g of mucin (Sigma-Aldrich), 0AE35 g of NaCl (AppliChem), 0AE2 g of CaCl 2 (Riedel-de Haën, Seelze, Germany) and 0AE2 g of KCl (Pronalab, Lisbon, Portugal). The pH was adjusted with NaOH (Pronalab) to 6AE8. Candida strains used for the present experiments were C. albicans 324LA ⁄ 94 (provided by the culture collection of Cardiff Dental School, Cardiff, UK) and C. glabrata D1 (obtained from the biofilm group of the Centre of Biological Engineering, University of Minho, Braga, Portugal), both being oral clinical isolates. Yeasts were first subcultured on Sabouraud dextrose agar medium (SDA; Liofilchem) at 37°C for 24 h. A cellular suspension of each yeast strain was prepared in Sabouraud dextrose broth (SDB; Liofilchem) medium and incubated overnight at 37°C and 120 rev min )1 . Afterwards, the cells were harvested by centrifugation (6500 g for 5 min at 15°C), washed twice in phosphate-buffered saline (PBS; pH 7) and adjusted to a concentration of 10 7 cells per ml in artificial saliva, using a Neubauer counting chamber.
Determination of minimum inhibitory concentrations (MICs)
MICs were determined for the six colloidal suspensions of SN against both Candida strains in accordance with the guidelines of the Clinical Laboratory Standards Institute (CLSI) (M27-A2), as detailed in a previous study (Monteiro et al. 2011) .
Biofilm formation and treatment with SN
Mature Candida biofilms aged 48 h were formed in 96-well microtiter plates according to Silva et al. (2010 
Biofilm quantification
Biomass of Candida biofilms treated with SN was evaluated by the crystal violet (CV) staining method. Initially, 200 ll of 99% methanol (Romil, Cambridge, UK) was added to the biofilms for 15 min to allow cell fixation. After, methanol was removed and the microtiter plates were dried at room temperature. Then, 200 ll of CV stain (1% v ⁄ v) (Merck) was added into the wells containing biofilms previously fixed. After 5 min, the excess of CV was removed and the plates were washed with deionized water and allowed to dry at room temperature. Afterwards, 200 ll of acetic acid (33% v ⁄ v) (Pronalab) was pipetted into each well to dissolve and remove the CV stain from the biofilms. Finally, absorbance was measured at 570 nm. The assays were performed in triplicate and on three separate occasions. For cultivable counts of Candida biofilm cells exposed to SN, biofilms were scraped from the wells and the suspensions obtained were vigorously vortexed for 5 min to disaggregate cells. Serial dilutions (in PBS) of each biofilm cell suspension were prepared and plated on SDA, and the plates were incubated at 37°C. After 24 h, the total number of colony forming units (CFUs) per unit area (log 10 CFU cm )2 ) of microtiter plate well was enumerated. For each condition studied, three separate experiments were performed.
Statistical analysis
Biofilm biomass and cultivable cells of the treated groups with SN were analysed using analysis of variance (anova) followed by Bonferroni test. Statistical analyses were performed with the spss software (SPSS -Statistical Package for the Social Sciences, Inc., Chicago, IL, USA) with significance of 5%.
Results
Silver colloidal nanoparticles characterization
SN at 540 lg ml )1 with different diameters were formed through the reduction of AgNO 3 with Na 3 C 6 H 5 O 7 followed by stabilization with NH 3 (N) or PVP (P). These procedures led to six different colloidal suspensions of SN, depending on the stabilizing agent used and the particle size: SN5-N, SN5-P, SN10-N, SN10-P, SN60-N and SN60-P. In the UV ⁄ Visible analysis ( Fig. 1) , the absorption peak of SN ranged from 430 to 460 nm, characterizing the nanosized silver particles. The absorption spectra of the SN5-N, SN5-P, SN10-N and SN10-P colloidal suspensions (Fig. 1aI ,aII,bI,bII) demonstrated well-defined plasmon bands centred at 430 nm. In the case of SN60-N and SN60-P ( Fig. 1cI ,cII), the absorption peaks were attained at approximately 460 nm, possibly because of the larger size of the particles. The symmetrical shapes of all plasmon bands in Fig. 1 confirmed the colloidal stability and sharp particle size distribution. These bands have been commonly assigned to nanoparticles having a spherical or spheroidal shape. TEM observations (Fig. 2) indicated that the nanoparticles were well formed, nearly spherical and dispersed, and with mean diameters of 5 (Fig. 2aI,aII) , 10 ( Fig. 2 bI,bII) and 60 nm (Fig. 2cI,cII) . Furthermore, it can be noted a few agglomerates of particles mainly when stabilized by PVP (Fig. 2bII,cII) .
Minimum inhibitory concentration
MICs of the six SN colloidal suspensions determined against planktonic cells of Candida are shown in Table 1 . It was possible to observe that the two species of Candida were susceptible to all the SN tested in very low concentrations. The lowest MIC values were against C. albicans 324LA ⁄ 94, using SN5-N, SN60-N and SN60-P (0AE4-0AE8 lg ml )1 ). Additionally, between the two Candida spp.
tested, C. glabrata D1 was the least susceptible to SN, with MIC values ranging from 0AE8 to 3AE3 lg ml )1 . With regard to the particle size and the stabilizing agents, interestingly, MIC values for each Candida species remained almost the same. Solutions of Na 3 C 6 H 5 O 7 , NH 3 and PVP, used as controls, did not exhibit any antifungal activity on the Candida spp. assayed.
Biofilm quantification
The results displayed in Fig. 3a show that SN were not effective in reducing total biomass of C. albicans 324LA ⁄ 94 biofilms. Interestingly, it was possible to note that, at concentrations ranging from 0AE4 to 108 lg ml )1 , all SN colloidal suspensions promoted an increase in biofilm biomass regardless of the silver concentration tested, except for SN5-N. When compared to the control values, the biomass increase was significant for SN10-N at concentrations of 1AE6 (P = 0.001), 6AE7 (P = 0.003), 13AE5 (P = 0.004), 27 (P = 0.019) and 216 lg ml )1 (P = 0.002), and for SN60-N at a concentration of 216 lg ml )1
(P = 0.032). Curiously, the comparisons of different colloidal suspensions at the same silver concentration showed no statistical differences (P > 0.05). However, on C. glabrata D1 (Fig. 3b) , all SN colloidal suspensions were very effective in reducing total biomass after 24 h of treatment of mature biofilms (formed for 48 h). When compared to the control groups (biofilms without SN) SN5-N, SN5-P, SN10-N, SN10-P, SN60-N and SN60-P showed significant biomass reduction at silver concentrations greater than or equal to 1AE6 (P = 0.001), 6AE7 (P = 0.011), 13AE5 (P = 0.002), 6AE7 (P = 0.001), 1AE6 (P = 0.011) and 6AE7 lg ml )1 (P < 0.001), respectively. In general, C. glabrata D1 demonstrated a biofilm biomass reduction dependent on silver concentration, achieving biomass reductions greater than 50% at a concentration of 13AE5 lg ml )1 and around 90% at a concentration of 108 lg ml )1 , for all colloidal suspensions tested.
Regarding the effect of SN on biofilm cultivable cells, Fig. 4 presents mean values and standard deviations of log 10 CFU cm )2 for both Candida species. For C. albicans 324LA ⁄ 94 (Fig. 4a) , after 24 h of biofilms treatment with SN colloidal suspensions, it was noted that the smaller particles (SN5-N and SN5-P) had the antifungal activity significantly increased from a concentration of 27 (P = 0.006) and 13AE5 lg ml )1 (P < 0.015), respectively. In addition, using SN5-N and SN5-P at a silver concentration of 216 lg ml )1 , there was 3AE51-log 10 (P < 0.001) and 3AE36-log 10 (P < 0.001) reduction in the number of CFUs, respectively, compared to the control groups. However, SN10-N similarly to SN10-P, and SN60-N similarly to SN60-P, started significant decrease in the number of CFUs in con- centrations over 54 (P = 0.002; P = 0.007) and 27 lg ml )1
(P = 0.027; P = 0.015), respectively, suggesting the type of stabilizing agent was not decisive for antifungal activity against C. albicans 324LA ⁄ 94 biofilms. Comparing the different SN colloidal suspensions within the same silver concentration, no significant statistical differences (P > 0.05) were found in the average number of log 10 CFUs. For C. glabrata D1 (Fig. 4b) , when each SN colloidal suspension was evaluated separately and compared to the control groups, the data showed that the SN5-N (P = 0.015) and SN10-P (P < 0.010) colloidal suspensions induced a significant decrease in the number of biofilm cells at silver concentrations above 54 lg ml )1 while for SN5-P (P < 0.001), SN10-N (P = 0.006), SN60-N (P = 0.010) and SN60-P (P = 0.009) this activity was statistically significant for silver concentrations greater than or equal to 27 lg ml )1 . SN5-P and SN60-P at silver concentration of 216 lg ml )1 exhibited the highest reductions in the average number of CFUs, with reductions of 4AE24-log 10 (P < 0.001) and 3AE72-log 10 (P < 0.001), respectively, when compared to the control groups. On the other hand, comparisons of the different SN colloidal suspensions within the same silver concentration did not indicate significant differences (P > 0.05). Thus, in general, according to the biofilm quantification results obtained in this study, the particle size and the type of SN stabilizing agent did not affect the antifungal activity of SN against Candida biofilms. 
Denture stomatitis is a pathogenic state common in complete denture wearers, and its infective causes include some micro-organisms, mainly C. albicans and C. glabrata (Coco et al. 2008) . Therefore, the ability of SN to inhibit Candida biofilms was evaluated against the aforesaid micro-organisms. The results of the present study did not allow the rejection of the null hypotheses, which are that the nanoparticle size and the type of stabilizing agent would not interfere with SN efficacy in decreasing total biomass and cultivable cells of Candida biofilms. Because SN may not only act in the biofilm cells, but also in their matrix, CV staining assay was performed to quantify the total biomass of Candida biofilms. This assay does not allow differentiation between living and dead cells, so it cannot be used for susceptibility testing of biofilms. CV staining was used as a complement to CFU enumeration. From Fig. 3 , it is possible to observe that the different SN were very effective against C. glabrata D1 biofilms, with significant biomass reduction at silver concentrations greater than or equal to 1AE6 lg ml )1 for all conditions (diameter and solution) assayed. For this species, all SN colloidal suspensions showed biomass reductions around 90% at a silver concentration of 108 lg ml )1
. However, in general, for C. albicans 324LA ⁄ 94 biofilms, there was some increase in biofilm biomass when compared to untreated biofilms, including different particle sizes and solutions. These differences in the effect of SN on both species could be due to their biofilm architectures, which present several dissimilarities. Candida glabrata biofilms are exclusively composed of blastospores and devoid of hyphal cells, while C. albicans is a polymorphic organism, able to grow as hyphae, pseudohyphae and blastospores . Accordingly, C. albicans biofilms are more complex and difficult to eradicate. Furthermore, the biofilm formation and matrix production processes are dependent upon species, strains and environmental conditions . When biofilms are exposed to stress conditions, physiological changes can occur to protect the cells (Mah and O'Toole mature biofilms after 24 h of treatment with silver nanoparticles (SN) with 5 (SN5), 10 (SN10) and 60 nm (SN60), which were stabilized using ammonia (N) and plyvinylpyrrolidone (P). Error bars indicate the standard deviations of the means. *P < 0AE05, as compared to the control groups by using a one-way anova followed by Bonferroni test. (a) Silver concentration (lg ml 
2001
). This may suggest an increased production of exopolymeric substances by C. albicans 324LA ⁄ 94 biofilms in the presence of SN, which could explain the increase in total biomass observed in Fig. 3a , accompanied by a slight decrease in the number of viable biofilm cells. Moreover, the silver concentrations above which significant reductions were detected in the number of biofilm cells of C. albicans 324LA ⁄ 94 (Fig. 4a) and C. glabrata D1 (Fig. 4b) , were about 17-135 and 16AE5 to 34-fold higher, respectively, than the corresponding MICs (Table 1) , confirming the lower susceptibility of biofilm cells. These MIC results revealed that all SN colloidal suspensions presented similar behaviours, all being fungicidal (in concentrations ranging from 0AE4 to 3AE3 lg ml )1 ) against the two Candida isolates when in the planktonic growth mode (Table 1) . Additionally, these fungicidal activities were confirmed by plating the content of each well on SDA. The data obtained are in agreement with the previously published results by Hawser and Douglas (1995) .
These authors found that all of the antifungal agents tested (amphotericin B, flucytosine, fluconazole, itraconazole and ketoconazole) showed much less activity against 48-h C. albicans biofilms than against planktonic cells. The drug concentrations that caused 50% inhibition in biofilms were 30-2000 times higher than the relevant MICs (Hawser and Douglas 1995) . In fact, C. albicans and C. glabrata form recalcitrant biofilms which are difficult to eradicate (Lewis 2001) , because of increasing tolerance to conventional antifungal therapy (Silva et al. 2012) . According to Silva et al. (2012) , the mechanisms of biofilm drug resistance ⁄ tolerance are not fully understood, but can be considered a multifactorial phenomenon. In combination or alone, these mechanisms include decreased growth rate (Lewis 2001) , heterogeneity, expression of resistance genes and presence of 'persister' cells within the biofilm (Lewis 2001; Mah and O'Toole 2001) . In addition, although some SN may diffuse inside the matrix through the water channels present in the biofilm after 24 h of treatment with silver nanoparticles (SN) with 5 (SN5), 10 (SN10) and 60 nm (SN60), which were stabilized using ammonia (N) and plyvinylpyrrolidone (P). Error bars indicate the standard deviations of the means. *P < 0AE05, when each SN colloidal suspension was evaluated separately and compared to the control groups by using a one-way anova followed by Bonferroni test. (a) Silver concentration (lg ml architecture, the micro-organisms present on the deeper layers may escape the treatment as the matrix hampers the drug diffusion (Kalishwaralal et al. 2010) . Regarding cell viability (Fig. 4) , although all SN presented a similar behaviour, they were more effective on C. glabrata D1 than against C. albicans 324LA ⁄ 94 biofilms. However, for both species in general, a significant reduction in the number of biofilm viable cells for silver concentrations at or higher than 13AE5 lg ml )1 was observed. Interestingly, the highest silver concentration (216 lg ml )1 ) did not have a significantly greater antibiofilm effect than the lowest concentrations (54 and 108 lg ml )1 ), characterizing a relatively weak doseresponse, except for SN5-P against C. glabrata D1, highlighting the similarities between the particles. Accordingly, these findings also suggest that it may not be necessary to use the highest silver concentrations. SN colloidal suspensions were prepared with NH 3 and PVP as stabilizers. NH 3 stabilizes metallic SN by the formation of soluble diammine silver (I) complexes, which trap free silver ions responsible for particle growth . The polymers of the PVP group bond on the SN surfaces through the nitrogen atom in their molecule (Kvítek et al. 2008) , resulting in flocculation. Kvítek et al. (2008) reported that despite the flocculation process, the SN stabilized by PVP are separated from each other through the chain of the polymer molecule, and these SN can interact with the cell wall of a micro-organism because of their high surface energy and mobility. Furthermore, according to the literature (Baker et al. 2005) , smaller SN are more effective than larger particles, because of a larger surface area available for interaction with cells. However, as referred, CV staining and CFU analysis (Figs 3 and 4) showed that the particle size range assayed and the type of stabilizing agent did not interfere with the antifungal activity of SN against Candida biofilms. Choi et al. (2010) demonstrated, through laser-scanning confocal microscopic observations, that the interactions of SN with Escherichia coli biofilm cells resulted in particle aggregation with a final average aggregate size of about 800 nm (an increase by a factor of 40). Moreover, Stewart and Franklin (2008) reported that biofilm features, such as oxygen availability, substrate, pH range and extracellular polymeric substances composition, may influence aggregation, dissolution and diffusive transport of SN. Taken together, all these observations reinforce the idea that SN aggregation may have occurred and, consequently, causing an increase in particle size. Probably due to this fact, it was not possible to observe any significant difference among SN colloidal suspensions and an inverse relationship between SN size and antifungal activity.
Furthermore, it would be reasonable to hypothesize that the aggregation of SN within the biofilms led to a particle size which conflicted extensively from that originally synthesized. This fact disallowed discriminating the effect of particle size and stabilizing agent on Candida biofilms. These observations emphasize that the original particle size may be a poor display of true nanoparticle size in biofilms and therefore also of antifungal activity. In other words, the results of the present study imply that biofilms are influencing by the aggregation of SN and that the size of nanoparticles and the type of stabilizing agent were not crucial to their positive effect on Candida biofilms. Possibly, only the well dispersed SN may act against Candida biofilms effectively. In summary, the particle size and the type of stabilizing agent do not interfere with the in vitro antimicrobial efficacy of SN. On the basis of these findings, additional investigations with silver colloidal nanoparticles will be needed regarding their therapeutic potential, namely to assess formulation and delivery means.
